Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Isomorphic Labs

Request full access

AI-first drug design and discovery company

London, United KingdomFounded 2021Biotech & Life Sciences

About Isomorphic Labs

Isomorphic Labs is a UK-based AI drug discovery and development company that uses artificial intelligence to design new medicines. It was founded in 2021 within Alphabet as a spin-out of DeepMind by Sir Demis Hassabis, who serves as its chief executive officer and also leads Google DeepMind, and it is headquartered in London's King's Cross.

The company builds on the scientific approach behind AlphaFold, the DeepMind system for predicting protein structures. Together with Google DeepMind, Isomorphic Labs co-developed AlphaFold 3, a model that predicts the structure and interactions of proteins, DNA, RNA, small molecules and other biomolecules. It is developing a unified AI drug design engine that combines predictive and generative models to identify drug targets, design candidate molecules and predict their properties, aiming to make drug discovery faster and more likely to succeed.

Isomorphic Labs applies this engine both to its own internal pipeline and to collaborations with pharmaceutical companies. It is advancing drug design programmes across multiple therapeutic areas and drug modalities, with a focus on moving its own candidates towards clinical development, and it has entered research partnerships with large pharmaceutical companies under which it can receive upfront payments, milestones and royalties.

The company brings together researchers from machine learning, structural biology, chemistry, physics and medicine, and positions itself as an AI-first drug design company with the long-term mission of solving disease with the help of artificial intelligence.

Source: Dealroom company data

At a glance

Status
Operational
Employees
408
Open positions
17
Dealroom signal
96.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Drug Development, Core AI, Verified Unicorns and $1B Exits, Tech for Biotech and Pharma, AI Drug Discovery, BIA Techbio UK
Technology
Artificial Intelligence, Deep Tech, Machine Learning
Business model
Manufacturing
Client focus
B2B

Open roles

38 open roles
From the company's careers page. The newest 12 of 38. Careers page ↗More startups hiring →

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B May 2026 $2.1B $8.4B GV · MGX · CapitalG · Alphabet | Google ↗
LATE VC Mar 2025 $600M $2.4B GV · Thrive Capital ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Isomorphic Labs website traffic

Latest recorded traffic for Isomorphic Labs is 130K monthly website visits, up 38.3% over the last three months. Isomorphic Labs's team grew 30.8% over the past year.

Latest monthly visits130K 3-month web change+38.3% 1-year team growth+30.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Isomorphic Labs in the London ecosystem

Live from Dealroom

The Isomorphic Labs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Series B and later3 investors entered at this stage

Team profiled 19 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Isomorphic Labs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.